Approvals/NMPA/Sitagliptin and Metformin Hydrochloride Sustained-release Tablets（Ⅱ）

Approved

化学药品

Sitagliptin and Metformin Hydrochloride Sustained-release Tablets（Ⅱ）

复星万邦（江苏）医药集团有限公司🇨🇳 National Medical Products Administration

Approval Id: 8nbPnz8bZM7
Approval Number: 国药准字H20255634
Generic Name: 西格列汀二甲双胍缓释片(Ⅱ)
Generic Name En: Sitagliptin and Metformin Hydrochloride Sustained-release Tablets（Ⅱ）
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 磷酸西格列汀50mg（以C₁₆H₁₅F₆N₅O计）和盐酸二甲双胍1000mg
Reg Date: 2025-09-30
Company Name: 复星万邦（江苏）医药集团有限公司
Company Address: 江苏省徐州市金山桥开发区综合区洞山南侧
Production Company Name: 复星万邦（江苏）医药集团有限公司
Production Company Address: 江苏省徐州市金山桥开发区综合区洞山南侧
Company Detail Path: /organization/fu-xing-mo-bang-jiang-su-yi-yao-ji-tuan-you-xian-gong-si
Production Company Detail Path: /organization/fu-xing-mo-bang-jiang-su-yi-yao-ji-tuan-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 30, 2025

Approval ID

8nbPnz8bZM7

Type

化学药品